Related Experiment Video
Updated: Mar 6, 2026
Subcutaneous Trigeminal Nerve Field Stimulation for Refractory Facial Pain
Published on: May 10, 2017
Computed Tomography-Guided Short-Term Gasserian Ganglion Stimulation for the Treatment of Idiopathic Trigeminal
1Department of Anesthesiology and Pain Medicine, Hubei Key Laboratory of Geriatric Anesthesia and Perioperative Brain Health, and Wuhan Clinical Research Center for Geriatric Anesthesia, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Background:
Idiopathic trigeminal neuralgia (ITN) affects approximately 0.16% to 0.3% of the population, with severe complications occurring in 15% of cases. Existing treatments often yield suboptimal outcomes.
Case Report:
This study evaluates the clinical efficacy of Gasserian ganglion stimulation (GGS) for ITN management in 2 patients. GGS led to significant symptom improvement in both patients, with one patient achieving complete remission. Compared to conventional therapies, GGS demonstrated a 30% higher efficacy rate, suggesting its potential as a superior therapeutic option. However, limitations include the small sample size and the mandibular nerve branch restriction.
Conclusions:
Despite the constraints, our findings are noteworthy, as previous GGS research has primarily focused on treatment failure or nerve damage. Our study suggests GGS could transform ITN management by providing a more effective and less invasive treatment alternative.
